Renoprotective Effects of DPP-4 Inhibitors

• Asıl Yazarlar: Daiji Kawanami (Yazar), Yuichi Takashi (Yazar), Hiroyuki Takahashi (Yazar), Ryoko Motonaga (Yazar), Makito Tanabe (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: MDPI AG, 2021-02-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Diabetic kidney disease (DKD) is the leading cause of end-stage renal disease (ESRD) worldwide. Dipeptidyl peptidase (DPP)-4 inhibitors are widely used in the treatment of patients with type 2 diabetes (T2D). DPP-4 inhibitors reduce glucose levels by inhibiting degradation of incretins. DPP-4 is a u...